Tolbutamide (BioDeep_00000001520)

 

Secondary id: BioDeep_00000408956

human metabolite blood metabolite


代谢物信息卡片


N-(Sulphonyl-p-methylbenzene)-n-N-butylurea

化学式: C12H18N2O3S (270.1038078)
中文名称: 甲苯磺丁脲
谱图信息: 最多检出来源 Homo sapiens(blood) 1.99%

分子结构信息

SMILES: CCCCN=C(O)NS(=O)(=O)c1ccc(C)cc1
InChI: InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)

描述信息

Tolbutamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It is structurally similar to acetohexamide, chlorpropamide and tolazamide and belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Tolbutamide appears to be metabolized in the liver. Tolbutamide and its metabolites are excreted in urine (75-85\\%) and feces.
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4159; ORIGINAL_PRECURSOR_SCAN_NO 4157
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8370; ORIGINAL_PRECURSOR_SCAN_NO 8367
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8423; ORIGINAL_PRECURSOR_SCAN_NO 8420
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8415; ORIGINAL_PRECURSOR_SCAN_NO 8413
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4159; ORIGINAL_PRECURSOR_SCAN_NO 4156
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4203; ORIGINAL_PRECURSOR_SCAN_NO 4202
ORIGINAL_ACQUISITION_NO 8354; CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 8351
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8415; ORIGINAL_PRECURSOR_SCAN_NO 8412
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4133; ORIGINAL_PRECURSOR_SCAN_NO 4130
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8326; ORIGINAL_PRECURSOR_SCAN_NO 8324
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8354; ORIGINAL_PRECURSOR_SCAN_NO 8351
CONFIDENCE standard compound; INTERNAL_ID 693; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4161; ORIGINAL_PRECURSOR_SCAN_NO 4157
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent
V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CA - Tests for diabetes
D007004 - Hypoglycemic Agents

同义名列表

53 个代谢物同义名

N-(Sulphonyl-p-methylbenzene)-n-N-butylurea; N-(Sulfonyl-p-methylbenzene)-n-N-butylurea; N-(p-Methylbenzenesulphonyl)-n-butylurea; N-(4-Methylbenzenesulphonyl)-n-butylurea; N-Butyl-n-(4-methylphenylsulphonyl)urea; N-(4-Methylbenzenesulfonyl)-n-butylurea; 1-Butyl-3-(p-methylphenylsulphonyl)urea; N-(4-Methylphenylsulphonyl)-n-butylurea; 3-butyl-1-(4-methylbenzenesulfonyl)urea; N-(p-Methylbenzenesulfonyl)-n-butylurea; N-(4-Methylphenylsulfonyl)-n-butylurea; N-Butyl-n-(4-methylphenylsulfonyl)urea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; 3-(p-Tolyl-4-sulphonyl)-1-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; Berlin-chemie brand OF tolbutamide; Berlin chemie brand OF tolbutamide; 1-Butyl-3-(p-tolylsulphonyl)urea; N-Butyl-n-(p-tolylsulphonyl)urea; N-Butyl-n-p-toluenesulphonylurea; 1-p-Toluenesulphonyl-3-butylurea; 1-Butyl-3-(p-tolylsulfonyl)urea; N-Butyl-n-p-toluenesulfonylurea; N-Butyl-n-(p-tolylsulfonyl)urea; Yamanouchi brand OF tolbutamide; 1-p-Toluenesulfonyl-3-butylurea; Valdecasas brand OF tolbutamide; Butamide brand OF tolbutamide; Hoechst brand OF tolbutamide; Aventis brand OF tolbutamide; Pfizer brand OF tolbutamide; Apotex brand OF tolbutamide; R.A.N. brand OF tolbutamide; Tolbutamide butamide brand; Tolbutamide aventis brand; Tolbutamide hoechst brand; Tolbutamide pfizer brand; Tolylsulphonylbutylurea; Tolylsulfonylbutylurea; N-N-Butyl-n-tosylurea; 1-Butyl-3-tosylurea; Tolbutamid r.a.n.; Apo-tolbutamide; Tolbutamidum; tolbutamide; Tolbutamida; Rastinon; Diabetol; Artosin; Dolipol; Orinase; Orabet; Diaval



数据库引用编号

29 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(5)

BioCyc(0)

PlantCyc(0)

代谢反应

50 个相关的代谢反应过程信息。

Reactome(50)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

2 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Hui-Lin Yang, Ying Li, Yi Chen, Si-Ying Chen, Yue-Ting Li, Yong Huang, Lin Zheng, Jing Huang, Yong-Lin Wang, Zi-Peng Gong. [Effect of Laportea bulbifera extract on CYP450 enzyme activities in rats by Cocktail probe drug method]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2022 Dec; 47(23):6320-6332. doi: 10.19540/j.cnki.cjcmm.20220623.204. [PMID: 36604876]
  • Xizi Liu, Shiyi Han, Qian Yang, Siyang Fan. Beneficial herb-drug interaction of Gnaphalium affine extract on benzbromarone: A pharmacokinetic and pharmacodynamic study in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2022 Jul; 102(?):154203. doi: 10.1016/j.phymed.2022.154203. [PMID: 35660349]
  • Seok Hwee Koo, Gaik Hong Soon, Alain Pruvost, Henri Benech, Tiing Leong Ang, Edmund Jon Deoon Lee, Daphne Shih Wen Ang. Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers. Naunyn-Schmiedeberg's archives of pharmacology. 2022 07; 395(7):815-826. doi: 10.1007/s00210-022-02235-1. [PMID: 35394133]
  • Shotaro Uehara, Nao Yoneda, Yuichiro Higuchi, Hiroshi Yamazaki, Hiroshi Suemizu. Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes. Xenobiotica; the fate of foreign compounds in biological systems. 2021 May; 51(5):582-589. doi: 10.1080/00498254.2021.1875515. [PMID: 33455497]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Sangita M Dutta, Guangping Chen, Smarajit Maiti. Profiles of Two Glycaemia Modifying Drugs on the Expression of Rat and Human Sulfotransferases. Current drug metabolism. 2021; 22(3):240-248. doi: 10.2174/1389200221666201130123837. [PMID: 33256575]
  • Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Bushra Mdkhana, Saba Al Heialy, Elaref Ratemi, Malak Alghamdi, Salah Abusnana, Tarek Kashour, Qutayba Hamid, Rabih Halwani. Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue. Archives of toxicology. 2020 12; 94(12):4037-4041. doi: 10.1007/s00204-020-02869-1. [PMID: 32808185]
  • Hana Nevídalová, Lenka Michalcová, Zdeněk Glatz. Applicability of capillary electrophoresis-frontal analysis for displacement studies: Effect of several drugs on l-tryptophan and lidocaine binding to human serum albumin. Journal of separation science. 2020 Nov; 43(22):4225-4233. doi: 10.1002/jssc.202000594. [PMID: 32966669]
  • Richard B van Breemen, Luying Chen, Alyssa Tonsing-Carter, Suzanne Banuvar, Elena Barengolts, Marlos Viana, Shao-Nong Chen, Guido F Pauli, Judy L Bolton. Pharmacokinetic Interactions of a Hop Dietary Supplement with Drug Metabolism in Perimenopausal and Postmenopausal Women. Journal of agricultural and food chemistry. 2020 May; 68(18):5212-5220. doi: 10.1021/acs.jafc.0c01077. [PMID: 32285669]
  • Yao Fu, Xiaoxiao Tian, Lingling Han, Yilin Li, Ying Peng, Jiang Zheng. Mechanism-based inactivation of cytochrome P450 2D6 by Notopterol. Chemico-biological interactions. 2020 May; 322(?):109053. doi: 10.1016/j.cbi.2020.109053. [PMID: 32198085]
  • Abhinav Sharma, Neha J Pagidipati, Robert M Califf, Darren K McGuire, Jennifer B Green, Dave Demets, Jyothis Thomas George, Hertzel C Gerstein, Todd Hobbs, Rury R Holman, Francesca C Lawson, Lawrence A Leiter, Marc A Pfeffer, Jane Reusch, Jeffrey S Riesmeyer, Matthew T Roe, Yves Rosenberg, Robert Temple, Stephen Wiviott, John McMurray, Christopher Granger. Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions. Circulation. 2020 03; 141(10):843-862. doi: 10.1161/circulationaha.119.041022. [PMID: 31992065]
  • Luying Chen, Richard B van Breemen. Validation of a sensitive UHPLC-MS/MS method for cytochrome P450 probe substrates caffeine, tolbutamide, dextromethorphan, and alprazolam in human serum reveals drug contamination of serum used for research. Journal of pharmaceutical and biomedical analysis. 2020 Feb; 179(?):112983. doi: 10.1016/j.jpba.2019.112983. [PMID: 31744669]
  • Mei-Ling Wu, Yi-Ping Lin, Yan-Li Wei, Hong-Jian Du, Xiao-Qian Ying, Wen-Zhuang Tan, Bi-E Tang. Calycosin Influences the Metabolism of Five Probe Drugs in Rats. Drug design, development and therapy. 2020; 14(?):429-434. doi: 10.2147/dddt.s236221. [PMID: 32099327]
  • Imocha Rajkumar Singh, Sivaprasad Mitra. Modulated Protein Binding Ability of Anti-Diabetic Drugs in Presence of Monodispersed Gold Nanoparticles and its Inhibitory Potential towards Advanced Glycated End (AGE) Product Formation. Journal of fluorescence. 2020 Jan; 30(1):193-204. doi: 10.1007/s10895-019-02485-y. [PMID: 31925653]
  • Jing Li, Ming-Rui Li, Bao Sun, Cheng-Ming Liu, Jing Ren, Wen-Qian Zhi, Pei-Yu Zhang, Hai-Ling Qiao, Na Gao. Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine. European journal of drug metabolism and pharmacokinetics. 2019 Dec; 44(6):787-796. doi: 10.1007/s13318-019-00565-9. [PMID: 31175627]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Shuhei Fukuno, Katsuhito Nagai, Kohei Yamamoto, Takehiro Tanimura, Takeshi Nabe, Hiroki Konishi. Pharmacokinetic interference of doxorubicin with tolbutamide due to reduced metabolic clearance with increased serum unbound fraction in rats. Biopharmaceutics & drug disposition. 2019 Jul; 40(7):225-233. doi: 10.1002/bdd.2195. [PMID: 31215040]
  • Luiz F Barella, Mario Rossi, Lu Zhu, Yinghong Cui, Fang C Mei, Xiaodong Cheng, Wei Chen, Vsevolod V Gurevich, Jürgen Wess. β-Cell-intrinsic β-arrestin 1 signaling enhances sulfonylurea-induced insulin secretion. The Journal of clinical investigation. 2019 06; 129(9):3732-3737. doi: 10.1172/jci126309. [PMID: 31184597]
  • Satoshi Endo, Namiki Miyagi, Toshiyuki Matsunaga, Akira Ikari. Rabbit dehydrogenase/reductase SDR family member 11 (DHRS11): Its identity with acetohexamide reductase with broad substrate specificity and inhibitor sensitivity, different from human DHRS11. Chemico-biological interactions. 2019 May; 305(?):12-20. doi: 10.1016/j.cbi.2019.03.026. [PMID: 30926317]
  • Zafar Iqbal, Grant Morahan, Mahreen Arooj, Alexandre N Sobolev, Shahid Hameed. Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress. European journal of medicinal chemistry. 2019 Apr; 168(?):154-175. doi: 10.1016/j.ejmech.2019.02.036. [PMID: 30818176]
  • Jing Wang, Zhi-Yi Zhang, Sharon Lu, Dan Powers, Vikram Kansra, Xiaodong Wang. Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2019 Mar; 27(3):819-827. doi: 10.1007/s00520-018-4331-x. [PMID: 30084103]
  • Chen Cheng, Jianchang Qian, Zhe Wang, Wanshu Li, Chengke Huang, Mengchun Chen, Yaoyao Dong, Lejing Lian, Wei Sun. Influences of Corydalis decumbens on the Activities of CYP450 Enzymes in Rats with a Cocktail Approach. BioMed research international. 2019; 2019(?):9614781. doi: 10.1155/2019/9614781. [PMID: 30800683]
  • Nele Seemann, Andrea Welling, Ingo Rustenbeck. The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca2+ channels and insulin secretion. Molecular and cellular endocrinology. 2018 09; 472(?):97-106. doi: 10.1016/j.mce.2017.11.024. [PMID: 29208420]
  • Cai-Fu Xue, Zhe Zhang, Yan Jin, Bin Zhu, Jun-Fen Xing, Guo Ma, Xiao-Qiang Xiang, Wei-Min Cai. Novel in vitro dynamic metabolic system for predicting the human pharmacokinetics of tolbutamide. Acta pharmacologica Sinica. 2018 Sep; 39(9):1522-1532. doi: 10.1038/aps.2017.201. [PMID: 29644999]
  • Shuhei Fukuno, Katsuhito Nagai, Ayano Horii, Kohei Yamamoto, Hiroki Konishi. Pharmacokinetics and metabolic elimination of tolbutamide in female rats: Comparison with male rats. Biopharmaceutics & drug disposition. 2018 Jul; 39(7):321-327. doi: 10.1002/bdd.2148. [PMID: 29978919]
  • Everett J Perkins, Maria Posada, P Kellie Turner, Jill Chappell, Wee Teck Ng, Chris Twelves. Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam. European journal of drug metabolism and pharmacokinetics. 2018 06; 43(3):355-367. doi: 10.1007/s13318-017-0447-5. [PMID: 29119333]
  • Till Stuhlmann, Rosa Planells-Cases, Thomas J Jentsch. LRRC8/VRAC anion channels enhance β-cell glucose sensing and insulin secretion. Nature communications. 2018 05; 9(1):1974. doi: 10.1038/s41467-018-04353-y. [PMID: 29773801]
  • Yi-An Bi, Sumathy Mathialagan, Laurie Tylaska, Myra Fu, Julie Keefer, Anna Vildhede, Chester Costales, A David Rodrigues, Manthena V S Varma. Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug. The Journal of pharmacology and experimental therapeutics. 2018 03; 364(3):390-398. doi: 10.1124/jpet.117.245951. [PMID: 29326367]
  • Madhuri Vaghela, Niteshkumar Sahu, Prashant Kharkar, Nancy Pandita. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats. Chemico-biological interactions. 2017 Dec; 278(?):141-151. doi: 10.1016/j.cbi.2017.10.015. [PMID: 29042257]
  • Agnieszka Szkudlarek, Danuta Pentak, Anna Ploch, Jadwiga Pożycka, Małgorzata Maciążek-Jurczyk. In Vitro Investigation of the Interaction of Tolbutamide and Losartan with Human Serum Albumin in Hyperglycemia States. Molecules (Basel, Switzerland). 2017 Dec; 22(12):. doi: 10.3390/molecules22122249. [PMID: 29258218]
  • Shuanghu Wang, Yanwen Dong, Ke Su, Jing Zhang, Linyi Wang, Anyue Han, Congcong Wen, Xianqin Wang, Yan He. Effect of codeine on CYP450 isoform activity of rats. Pharmaceutical biology. 2017 Dec; 55(1):1223-1227. doi: 10.1080/13880209.2017.1297466. [PMID: 28253826]
  • Pengqi Guo, Xinya Xu, Guoning Chen, Kamran Bashir, Hua Shu, Yanhui Ge, Wanghui Jing, Zhimin Luo, Chun Chang, Qiang Fu. On-Line two dimensional liquid chromatography based on skeleton type molecularly imprinted column for selective determination of sulfonylurea additive in Chinese patent medicines or functional foods. Journal of pharmaceutical and biomedical analysis. 2017 Nov; 146(?):292-301. doi: 10.1016/j.jpba.2017.09.008. [PMID: 28903088]
  • Jia Sun, Yuan Lu, Yueting Li, Jie Pan, Chunhua Liu, Zipeng Gong, Jing Huang, Jiang Zheng, Lin Zheng, Yongjun Li, Ting Liu, Yonglin Wang. Influence of Shenxiong Glucose Injection on the Activities of Six CYP Isozymes and Metabolism of Warfarin in Rats Assessed Using Probe Cocktail and Pharmacokinetic Approaches. Molecules (Basel, Switzerland). 2017 Nov; 22(11):. doi: 10.3390/molecules22111994. [PMID: 29156621]
  • Agnieszka Szkudlarek, Danuta Pentak, Anna Ploch, Jadwiga Pożycka, Małgorzata Maciążek-Jurczyk. Effect of Temperature on Tolbutamide Binding to Glycated Serum Albumin. Molecules (Basel, Switzerland). 2017 Mar; 22(4):. doi: 10.3390/molecules22040569. [PMID: 28362348]
  • Shu-fen He, Wen-zheng Ju, Hao-bin Hu, Li-jing Zhu, Qian Zhang, Guo-liang Dai. [Change of hepatic drug metabolism enzymes in rat depression model with kidney-yang deficiency]. Yao xue xue bao = Acta pharmaceutica Sinica. 2017 Feb; 52(2):258-63. doi: . [PMID: 29979512]
  • Jian Lu, TongGui Ding, Xuan Qin, MingYao Liu, Xin Wang. In vitro and in vivo evaluation of cucurbitacin E on rat hepatic CYP2C11 expression and activity using LC-MS/MS. Science China. Life sciences. 2017 Feb; 60(2):215-224. doi: 10.1007/s11427-015-4911-7. [PMID: 26354504]
  • Deepti Pandita, Neelam Kumari, Viney Lather. A Self-nanoemulsifying Drug Delivery System for Poorly Water Soluble Tolbutamide: Development, Optimization and Pharmacodynamic Studies. Pharmaceutical nanotechnology. 2017; 5(4):285-300. doi: 10.2174/2211738505666170915154920. [PMID: 28925888]
  • Min Xu, Huaqiao Tang, Qian Rong, Yuanli Zhang, Yinglun Li, Ling Zhao, Gang Ye, Fei Shi, Cheng Lv. The Effects of Formaldehyde on Cytochrome P450 Isoform Activity in Rats. BioMed research international. 2017; 2017(?):6525474. doi: 10.1155/2017/6525474. [PMID: 28555194]
  • Rachumallu Ramakrishna, Manisha Bhateria, Rajbir Singh, Rabi Sankar Bhatta. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes. The Journal of steroid biochemistry and molecular biology. 2016 10; 163(?):183-92. doi: 10.1016/j.jsbmb.2016.05.018. [PMID: 27224941]
  • Wendy Lee, James J Crawford, Ignacio Aliagas, Lesley J Murray, Suzanne Tay, Weiru Wang, Christopher E Heise, Klaus P Hoeflich, Hank La, Simon Mathieu, Robert Mintzer, Sreemathy Ramaswamy, Lionel Rouge, Joachim Rudolph. Synthesis and evaluation of a series of 4-azaindole-containing p21-activated kinase-1 inhibitors. Bioorganic & medicinal chemistry letters. 2016 08; 26(15):3518-24. doi: 10.1016/j.bmcl.2016.06.031. [PMID: 27346791]
  • Hodaka Yamada, Masashi Yoshida, Kiyonori Ito, Katsuya Dezaki, Toshihiko Yada, San-E Ishikawa, Masafumi Kakei. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells. Scientific reports. 2016 05; 6(?):25912. doi: 10.1038/srep25912. [PMID: 27180622]
  • Sachina Suzuki, Yoko Sato, Keizo Umegaki, Tsuyoshi Chiba. Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2016; 136(9):1297-305. doi: 10.1248/yakushi.16-00034. [PMID: 27592832]
  • Jianshe Ma, Shuanghu Wang, Meiling Zhang, Qingwei Zhang, Yunfang Zhou, Chongliang Lin, Guanyang Lin, Xianqin Wang. Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats. Biomedical chromatography : BMC. 2015 Aug; 29(8):1203-12. doi: 10.1002/bmc.3409. [PMID: 25582505]
  • L Franssens, J Lesuisse, Y Wang, B De Ketelaere, E Willems, A Koppenol, X Guo, J Buyse, E Decuypere, N Everaert. Prenatal tolbutamide treatment alters plasma glucose and insulin concentrations and negatively affects the postnatal performance of chickens. Domestic animal endocrinology. 2015 Jul; 52(?):35-42. doi: 10.1016/j.domaniend.2015.01.004. [PMID: 25727896]
  • Xinwen Wang, Hao-Jie Zhu, Juliana Munoz, Bill J Gurley, John S Markowitz. An ex vivo approach to botanical-drug interactions: a proof of concept study. Journal of ethnopharmacology. 2015 Apr; 163(?):149-56. doi: 10.1016/j.jep.2015.01.021. [PMID: 25623616]
  • Guo-Xin Hu, Pei-Pei Pan, Zeng-Shou Wang, Li-Ping Yang, Da-Peng Dai, Shuang-Hu Wang, Guang-Hui Zhu, Xiang-Jun Qiu, Tao Xu, Jun Luo, Qing-Quan Lian, Ren-Shan Ge, Jian-Ping Cai. In vitro and in vivo characterization of 13 CYP2C9 allelic variants found in Chinese Han population. Drug metabolism and disposition: the biological fate of chemicals. 2015 Apr; 43(4):561-9. doi: 10.1124/dmd.114.061200. [PMID: 25614704]
  • Ibrahim Hasibu, Dany Patoine, Sylvie Pilote, Benoit Drolet, Chantale Simard. The guinea-pig expresses functional CYP2C and P-glycoprotein: further validation of its usefulness in drug biotransformation/transport studies. Biopharmaceutics & drug disposition. 2015 Apr; 36(3):183-203. doi: 10.1002/bdd.1931. [PMID: 25472529]
  • Sridhar Veeraraghavan, Srikant Viswanadha, Satheeshmanikandan Thappali, Babu Govindarajulu, Swaroopkumar Vakkalanka, Manivannan Rangasamy. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study. Journal of pharmaceutical and biomedical analysis. 2015 Mar; 107(?):151-8. doi: 10.1016/j.jpba.2014.11.041. [PMID: 25594893]
  • Xin-shuai Wang, Xiao-chen Hu, Gui-ling Chen, Xiang Yuan, Rui-na Yang, Shuo Liang, Jing Ren, Jia-chun Sun, Guo-qiang Kong, She-gan Gao, Xiao-shan Feng. Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats. Phytotherapy research : PTR. 2015 Mar; 29(3):366-72. doi: 10.1002/ptr.5260. [PMID: 25447838]
  • Yu-xin Zang, Bing-ting Sun, Wen-zhu Zhao, Na Rong, Guo-liang Dai, Wen-zheng Ju, Heng-shan Tan. [Study of change in activity of hepatic drug metabolism enzymes in rat model of chronic unpredictable mild stress]. Yao xue xue bao = Acta pharmaceutica Sinica. 2015 Mar; 50(3):319-25. doi: . [PMID: 26118111]
  • Ju-Hee Ryu, Ji-Sun Park, Min-Ho Jo, Joo-Il Kim, Wang-Seob Shim, Bo-Hyung Kim, Sung-Vin Yim, Jongki Hong, Kyung-Tae Lee. Development and validation of an LC-MS/MS method for the determination of pelubiprofen and its active metabolite, trans-alcohol, in human plasma and its application to pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2015 Mar; 983-984(?):62-7. doi: 10.1016/j.jchromb.2014.12.037. [PMID: 25618252]
  • Kezhi Lin, Qingwei Zhang, Zezheng Liu, Suping Yang, Yingying Lin, Congcong Wen, Yuancai Zheng. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities. International journal of clinical and experimental pathology. 2015; 8(5):5584-90. doi: . [PMID: 26191268]
  • Sajjad Salari, Maedeh Ghasemi, Javad Fahanik-Babaei, Reza Saghiri, Remy Sauve, Afsaneh Eliassi. Evidence for a KATP Channel in Rough Endoplasmic Reticulum (rerKATP Channel) of Rat Hepatocytes. PloS one. 2015; 10(5):e0125798. doi: 10.1371/journal.pone.0125798. [PMID: 25950903]
  • Lin Zheng, Yuan Lu, Xu Cao, Yong Huang, Yue Liu, Li Tang, Shang-Gao Liao, Ai-Min Wang, Yong-Jun Li, Yan-Yu Lan, Yong-Lin Wang. Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs. Journal of ethnopharmacology. 2014 Dec; 158 Pt A(?):276-82. doi: 10.1016/j.jep.2014.10.031. [PMID: 25446640]
  • J K Jellyman, O A Valenzuela, V L Allen, N B Holdstock, A L Fowden. Sex-associated differences in pancreatic β cell function in healthy preweaning pony foals. Equine veterinary journal. 2014 Nov; 46(6):722-8. doi: 10.1111/evj.12230. [PMID: 24423054]
  • Ahmed A Al Balushi, Reuven Gordon. A label-free untethered approach to single-molecule protein binding kinetics. Nano letters. 2014 Oct; 14(10):5787-91. doi: 10.1021/nl502665n. [PMID: 25211555]
  • Marina Kawaguchi-Suzuki, Reginald F Frye, Hao-Jie Zhu, Bryan J Brinda, Kenneth D Chavin, Hilary J Bernstein, John S Markowitz. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Drug metabolism and disposition: the biological fate of chemicals. 2014 Oct; 42(10):1611-6. doi: 10.1124/dmd.114.057232. [PMID: 25028567]
  • Kim D Mooiman, Andrew K L Goey, Tomy J Huijbregts, Roel F Maas-Bakker, Jos H Beijnen, Jan H M Schellens, Irma Meijerman. The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity. The Journal of pharmacy and pharmacology. 2014 Sep; 66(9):1339-46. doi: 10.1111/jphp.12259. [PMID: 24730468]
  • Y Huang, S-L Zheng, Z-S Xu, Y Hou. Effects of unprocessed vs. cooked-processed Gastrodia elata on cytochrome P450 enzymes in rats. Drug research. 2014 Aug; 64(8):424-8. doi: 10.1055/s-0033-1361107. [PMID: 24285404]
  • Mi Ran Choi, Mi Hye Kwon, Yong Yeon Cho, Hye Duck Choi, Yu Chul Kim, Hee Eun Kang. Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats. Biopharmaceutics & drug disposition. 2014 Jul; 35(5):264-74. doi: 10.1002/bdd.1893. [PMID: 24590592]
  • Anette P Gjesing, Malene Hornbak, Kristine H Allin, Claus T Ekstrøm, Søren A Urhammer, Hans Eiberg, Oluf Pedersen, Torben Hansen. High heritability and genetic correlation of intravenous glucose- and tolbutamide-induced insulin secretion among non-diabetic family members of type 2 diabetic patients. Diabetologia. 2014 Jun; 57(6):1173-81. doi: 10.1007/s00125-014-3207-y. [PMID: 24604100]
  • Chea-Ha Kim, Soo-Hyun Park, Yun-Beom Sim, Sung-Su Kim, Su-Jin Kim, Su-Min Lim, Jun-Sub Jung, Hong-Won Suh. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice. Brain research. 2014 May; 1564(?):33-40. doi: 10.1016/j.brainres.2014.03.046. [PMID: 24713348]
  • Yu-Jin Guo, Shuang-Li Zheng. Effect of myricetin on cytochrome P450 isoforms CYP1A2, CYP2C9 and CYP3A4 in rats. Die Pharmazie. 2014 Apr; 69(4):306-10. doi: . [PMID: 24791597]
  • Dong-Lou Liang, Shuang-Li Zheng. Effects of icaritin on cytochrome P450 enzymes in rats. Die Pharmazie. 2014 Apr; 69(4):301-5. doi: NULL. [PMID: 24791596]
  • Hong-Jaan Wang, Li-Heng Pao, Cheng-Huei Hsiong, Tung-Yuan Shih, Meei-Shyuan Lee, Oliver Yoa-Pu Hu. Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship. The AAPS journal. 2014 Mar; 16(2):258-68. doi: 10.1208/s12248-013-9549-4. [PMID: 24431079]
  • Ganesh Cherala, Jacob Pearson, Cheryl Maslen, Alison Edelman. An ethinyl estradiol-levonorgestrel containing oral contraceptive does not alter cytochrome P4502C9 in vivo activity. Drug metabolism and disposition: the biological fate of chemicals. 2014 Mar; 42(3):323-5. doi: 10.1124/dmd.113.054346. [PMID: 24368832]
  • Ren-Ai Xu, Zhi-Sheng Xu, Ren-Shan Ge. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats. Journal of ethnopharmacology. 2014 Feb; 151(3):1141-1146. doi: 10.1016/j.jep.2013.12.025. [PMID: 24373810]
  • Qin Li, Ying Liu, Jianjie Jiao, Caili Zhang, Jianshi Lou. Assessment of effects of IR and IPC on activities of cytochrome P450 isozymes in rats by a five-drug cocktail approach. Drug development and industrial pharmacy. 2014 Feb; 40(2):157-62. doi: 10.3109/03639045.2012.752499. [PMID: 23339682]
  • Yi Huang, Shuang-li Zheng, Hai-yan Zhu, Zhi-sheng Xu, Ren-ai Xu. Effects of aescin on cytochrome P450 enzymes in rats. Journal of ethnopharmacology. 2014; 151(1):583-90. doi: 10.1016/j.jep.2013.11.016. [PMID: 24252494]
  • Mizuki Horiuchi, Soichiro Moriyama, Yukiko Takahata, Tetsuya Aiba, Yuji Kurosaki. Effects of peritoneal dialysis on pharmacotherapy: a deductive pharmacokinetic-model approach to predict drug concentration profiles in plasma and peritoneal fluid. Drug metabolism and pharmacokinetics. 2014; 29(2):154-61. doi: 10.2133/dmpk.dmpk-13-rg-067. [PMID: 24025988]
  • Kaori Yokotani, Tsuyoshi Chiba, Yoko Sato, Keizo Umegaki. Coleus forskohlii extract attenuates the hypoglycemic effect of tolbutamide in vivo via a hepatic cytochrome P450-mediated mechanism. Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan. 2014; 55(2):73-8. doi: 10.3358/shokueishi.55.73. [PMID: 24990552]
  • Hina Zahid, Ghazala H Rizwani, Huma Shareef, Raheela Khursheed, Ambreen Huma, S M Farid Hasan. Antihyperglycemic and hypolipidemic effects of Hibiscus schizopetalus (Mast) Hook in alloxan-induced diabetic rats. Pakistan journal of pharmaceutical sciences. 2014 Jan; 27(1):83-9. doi: ". [PMID: 24374457]
  • Frida Gustafsson, Alison J Foster, Sunil Sarda, Matthew H Bridgland-Taylor, J Gerry Kenna. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. Toxicological sciences : an official journal of the Society of Toxicology. 2014 Jan; 137(1):189-211. doi: 10.1093/toxsci/kft223. [PMID: 24085192]
  • Xianqin Wang, Anyue Han, Congcong Wen, Mengchun Chen, Xinxin Chen, Xuezhi Yang, Jianshe Ma, Guanyang Lin. The effects of H2S on the activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in vivo in rat. International journal of molecular sciences. 2013 Dec; 14(12):24055-63. doi: 10.3390/ijms141224055. [PMID: 24336065]
  • Tom S Chan, Hongbin Yu, Amanda Moore, Salman R Khetani, Salman R Kehtani, Donald Tweedie. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac. Drug metabolism and disposition: the biological fate of chemicals. 2013 Dec; 41(12):2024-32. doi: 10.1124/dmd.113.053397. [PMID: 23959596]
  • Sweta Tandra, Naga Chalasani, David R Jones, Samer Mattar, Stephen D Hall, Raj Vuppalanchi. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients. Annals of surgery. 2013 Aug; 258(2):262-9. doi: 10.1097/sla.0b013e31827a0e82. [PMID: 23222033]
  • Toshihiko Ikeda, Shinsuke Aoyama, Zenzaburo Tozuka, Kohei Nozawa, Yoshimi Hamabe, Takao Matsui, Michiko Kainuma, Setsuo Hasegawa, Kazuya Maeda, Yuichi Sugiyama. Microdose pharmacogenetic study of ¹⁴C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2013 Jul; 49(4):642-8. doi: 10.1016/j.ejps.2013.05.016. [PMID: 23727057]
  • Jian-Long Chen, Yu-Ling Zhang, Yu Dong, Ji-Yu Gong, Han-Ming Cui. [CYP450 enzyme inhibition of berberine in pooled human liver microsomes by cocktail probe drugs]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2013 Jun; 38(12):2009-14. doi: . [PMID: 24066602]
  • Renli Teng, Patrick Mitchell, Kathleen Butler. Evaluation of the pharmacokinetic interaction between ticagrelor and tolbutamide, a cytochrome P450 2C9 substrate, in healthy volunteers. International journal of clinical pharmacology and therapeutics. 2013 Apr; 51(4):305-12. doi: 10.5414/cp201749. [PMID: 23380426]
  • Bryan Stone, Leah Evans, John Coleman, Daniel Kuebler. Genetic and pharmacological manipulations that alter metabolism suppress seizure-like activity in Drosophila. Brain research. 2013 Feb; 1496(?):94-103. doi: 10.1016/j.brainres.2012.12.007. [PMID: 23247062]
  • Jingwen Gao, Zhan Shi, Shuzhen Zhu, George Q Li, Ru Yan, Meicun Yao. Influences of processed rhubarbs on the activities of four CYP isozymes and the metabolism of saxagliptin in rats based on probe cocktail and pharmacokinetics approaches. Journal of ethnopharmacology. 2013 Jan; 145(2):566-72. doi: 10.1016/j.jep.2012.11.030. [PMID: 23207062]
  • Xianqin Wang, Xiaole Chen, Mengchun Chen, Guoxin Hu, Jianshe Ma, Jianchun Pan, Lufeng Hu, Guanyang Lin. Assessment of effects of chronic hydrogen sulfide poisoning on cytochrome P450 isoforms activity of rats by cocktail approach. Biological & pharmaceutical bulletin. 2013; 36(10):1627-33. doi: 10.1248/bpb.b13-00502. [PMID: 24088256]
  • J K Jellyman, V L Allen, N B Holdstock, A L Fowden. Glucocorticoid overexposure in neonatal life alters pancreatic beta-cell function in newborn foals. Journal of animal science. 2013 Jan; 91(1):104-10. doi: 10.2527/jas.2012-5475. [PMID: 23100584]
  • Yan Liu, Xiang Li, Chunjuan Yang, Sheng Tai, Xiangning Zhang, Gaofeng Liu. UPLC-MS-MS method for simultaneous determination of caffeine, tolbutamide, metoprolol, and dapsone in rat plasma and its application to cytochrome P450 activity study in rats. Journal of chromatographic science. 2013 Jan; 51(1):26-32. doi: 10.1093/chromsci/bms100. [PMID: 22695883]
  • Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals. 2012 Dec; 40(12):2332-41. doi: 10.1124/dmd.112.047068. [PMID: 22961681]
  • Kuldeep Sharma, Gopal V Pawar, Sanjeev Giri, Sriram Rajagopal, Ramesh Mullangi. Development and validation of a highly sensitive LC-MS/MS-ESI method for the determination of bicalutamide in mouse plasma: application to a pharmacokinetic study. Biomedical chromatography : BMC. 2012 Dec; 26(12):1589-95. doi: 10.1002/bmc.2736. [PMID: 22495777]
  • Yoshikazu Miura, Yuichi Hori, Shinzo Kimura, Hiroyuki Hachiya, Yuichirou Sakurai, Kenichi Inoue, Tokihiko Sawada, Keiichi Kubota. Triphenyltin impairs insulin secretion by decreasing glucose-induced NADP(H) and ATP production in hamster pancreatic β-cells. Toxicology. 2012 Sep; 299(2-3):165-71. doi: 10.1016/j.tox.2012.05.021. [PMID: 22664483]
  • Ru Feng, Xuelin Zhou, Penelope M Y Or, Jing-Yi Ma, Xiang-Shan Tan, Jie Fu, Chao Ma, Jian-Gong Shi, Chun-Tao Che, Yan Wang, John H K Yeung. Enzyme kinetic and molecular docking studies on the metabolic interactions of 1-hydroxy-2,3,5-trimethoxy-xanthone, isolated from Halenia elliptica D. Don, with model probe substrates of human cytochrome P450 enzymes. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2012 Sep; 19(12):1125-33. doi: 10.1016/j.phymed.2012.06.009. [PMID: 22819301]
  • Takashi Nakakura, Chihiro Mogi, Masayuki Tobo, Hideaki Tomura, Koichi Sato, Masaki Kobayashi, Hiroshi Ohnishi, Shigeyasu Tanaka, Mitsutoshi Wayama, Tetsuya Sugiyama, Tadahiro Kitamura, Akihiro Harada, Fumikazu Okajima. Deficiency of proton-sensing ovarian cancer G protein-coupled receptor 1 attenuates glucose-stimulated insulin secretion. Endocrinology. 2012 Sep; 153(9):4171-80. doi: 10.1210/en.2012-1164. [PMID: 22733973]
  • Abbas Ahmadi, Mohsen Khalili, Seyedsobhan Seyedhoseyni, Ehsan Maadi Roudsari, Babak Nahri-Niknafs. Synthesis, antidiabetic and hypolipidemic activities of new diethylamine and triethoxysilyl derivatives of tolbutamide on rats. Medicinal chemistry (Shariqah (United Arab Emirates)). 2012 Sep; 8(5):964-9. doi: 10.2174/157340612802084261. [PMID: 22741777]
  • Dayong Si, Juan Wang, Yifan Zhang, Dafang Zhong, Hui Zhou. Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2. Biopharmaceutics & drug disposition. 2012 Sep; 33(6):342-5. doi: 10.1002/bdd.1804. [PMID: 22886551]
  • Thomas J Velenosi, Angel Y N Fu, Shuhua Luo, Hao Wang, Bradley L Urquhart. Down-regulation of hepatic CYP3A and CYP2C mediated metabolism in rats with moderate chronic kidney disease. Drug metabolism and disposition: the biological fate of chemicals. 2012 Aug; 40(8):1508-14. doi: 10.1124/dmd.112.045245. [PMID: 22573661]
  • Ariane Wohlfarth, Jana Naue, Sabine Lutz-Bonengel, Sebastian Dresen, Volker Auwärter. Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping. Journal of clinical pharmacology. 2012 Aug; 52(8):1200-14. doi: 10.1177/0091270011410570. [PMID: 21885687]
  • Hsien-Tsung Yao, Yi-Wei Chang, Naoto Uramaru, Yoko Watanabe, Shigeyuki Kitamura, Yueh-Hsiung Kuo, Chong-Kuei Lii, Teng-Kuang Yeh. Effects of Bu-Zhong-Yi-Qi-Tang on hepatic drug-metabolizing enzymes and plasma tolbutamide concentration in rats. Journal of ethnopharmacology. 2012 Jun; 142(1):121-8. doi: 10.1016/j.jep.2012.04.024. [PMID: 22564357]
  • Oliver J Mace, Marcus Schindler, Sonal Patel. The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. The Journal of physiology. 2012 Jun; 590(12):2917-36. doi: 10.1113/jphysiol.2011.223800. [PMID: 22495587]
  • Sun-Hee Lee, Sung-Won Lim, Young-Mi Lee, Hoi-Seon Lee, Dae-Ki Kim. Polysaccharide isolated from Triticum aestivum stimulates insulin release from pancreatic cells via the ATP-sensitive K+ channel. International journal of molecular medicine. 2012 May; 29(5):913-9. doi: 10.3892/ijmm.2012.905. [PMID: 22322245]
  • G Zadoyan, D Rokitta, S Klement, A Dienel, R Hoerr, T Gramatté, U Fuhr. Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. European journal of clinical pharmacology. 2012 May; 68(5):553-60. doi: 10.1007/s00228-011-1174-5. [PMID: 22189672]
  • Mark Walzer, Ihor Bekersky, Robert A Blum, Dwain Tolbert. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes. Pharmacotherapy. 2012 Apr; 32(4):340-53. doi: 10.1002/j.1875-9114.2012.01028.x. [PMID: 22422635]
  • Marie Croft, Brendan Keely, Ian Morris, Lan Tann, Graham Lappin. Predicting drug candidate victims of drug-drug interactions, using microdosing. Clinical pharmacokinetics. 2012 Apr; 51(4):237-46. doi: 10.2165/11597070-000000000-00000. [PMID: 22335429]